Grand rounds in methodology: key considerations for implementing machine learning solutions in quality improvement initiatives.

healthcare quality improvement implementation science information technology quality improvement methodologies

Journal

BMJ quality & safety
ISSN: 2044-5423
Titre abrégé: BMJ Qual Saf
Pays: England
ID NLM: 101546984

Informations de publication

Date de publication:
23 Nov 2023
Historique:
received: 10 04 2023
accepted: 04 11 2023
medline: 5 12 2023
pubmed: 5 12 2023
entrez: 5 12 2023
Statut: aheadofprint

Résumé

Machine learning (ML) solutions are increasingly entering healthcare. They are complex, sociotechnical systems that include data inputs, ML models, technical infrastructure and human interactions. They have promise for improving care across a wide range of clinical applications but if poorly implemented, they may disrupt clinical workflows, exacerbate inequities in care and harm patients. Many aspects of ML solutions are similar to other digital technologies, which have well-established approaches to implementation. However, ML applications present distinct implementation challenges, given that their predictions are often complex and difficult to understand, they can be influenced by biases in the data sets used to develop them, and their impacts on human behaviour are poorly understood. This manuscript summarises the current state of knowledge about implementing ML solutions in clinical care and offers practical guidance for implementation. We propose three overarching questions for potential users to consider when deploying ML solutions in clinical care: (1) Is a clinical or operational problem likely to be addressed by an ML solution? (2) How can an ML solution be evaluated to determine its readiness for deployment? (3) How can an ML solution be deployed and maintained optimally? The Quality Improvement community has an essential role to play in ensuring that ML solutions are translated into clinical practice safely, effectively, and ethically.

Identifiants

pubmed: 38050138
pii: bmjqs-2022-015713
doi: 10.1136/bmjqs-2022-015713
pii:
doi:

Types de publication

Journal Article

Langues

eng

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: AAV and MM are co-inventors of CHARTwatch, an artificial intelligence early warning system for patient deterioration and have the potential to acquire minority interests in a start-up company, Signal1.

Auteurs

Amol A Verma (AA)

Unity Health Toronto, Toronto, Ontario, Canada amol.verma@mail.utoronto.ca.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Medicine, University of Toronto Faculty of Medicine, Toronto, Ontario, Canada.

Patricia Trbovich (P)

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Centre for Quality Improvement and Patient Safety, Department of Medicine, University of Toronto, Toronto, ON, Canada.
North York General Hospital, Toronto, ON, Canada.

Muhammad Mamdani (M)

Unity Health Toronto, Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Medicine, University of Toronto Faculty of Medicine, Toronto, Ontario, Canada.

Kaveh G Shojania (KG)

Medicine, University of Toronto Faculty of Medicine, Toronto, Ontario, Canada.
Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

Classifications MeSH